Veracyte Inc (NASDAQ:VCYT)
| 28.46 Delayed Data As of Jul 07 |  -0.12 / -0.42%Today’s Change | 13.90 Today|||52-Week Range 31.18 | +1.93% Year-to-Date |
Latest VCYT News | Press Releases
No recent news for Veracyte Inc.
Today’s Trading
| Previous close | 28.58 |
| Today’s open | 28.20 |
| Day’s range | 28.20 - 29.81 |
| Volume | 24,767 |
| Average volume (3 months) | 523,071 |
| Market cap | $1.4B |
Data as of 3:59pm ET, 07/07/2020
Growth & Valuation
| Earnings growth (last year) | +56.04% |
| Earnings growth (this year) | -197.04% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +30.82% |
| P/E ratio | NM |
| Price/Sales | 10.70 |
| Price/Book | 5.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CDNACareDx Inc | -0.16 | -0.46% |
| VIVOMeridian Bioscience ... | -0.82 | -3.36% |
| LNTHLantheus Holdings In... | -0.33 | -2.25% |
| AXDXAccelerate Diagnosti... | -0.63 | -3.93% |
Data as of 4:07pm ET, 07/07/2020
Financials
| Next reporting date | August 4, 2020 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $120.4M |
| Annual profit (last year) | -$12.6M |
| Net profit margin | -10.47% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
